Literature DB >> 18515036

The effect of venous thrombus location and extent on the development of post-thrombotic signs and symptoms.

Nicos Labropoulos1, Thomas Waggoner, William Sammis, Saughar Samali, Peter J Pappas.   

Abstract

OBJECTIVE: This prospective study determined the incidence of signs and symptoms of chronic venous disease and recurrent venous thrombotic events (VTE) in relation to the location and extent of the initial venous thrombus.
METHODS: A first episode of acute deep vein thrombosis (DVT) occurred in 120 lower extremities of 105 patients (59 men; mean age, 54 years [range, 23-82 years]). Patients who presented with pain, swelling, or signs and symptoms of pulmonary embolism of <10 days were included. The DVT was diagnosed with duplex ultrasound (DUS) imaging. Patients were grouped by those having thrombosis in one venous segment (group A) or multiple levels (group B). Patients were treated with heparin and warfarin. Patients with at least 1-year of follow-up with clinical and DUS were included.
RESULTS: No difference was found in the duration of signs and symptoms at presentation. The median follow-up was 3.4 years (range, 1.2-7 years). More symptomatic limbs were seen in group B (71 of 79) compared with group A (21 of 41; P < .001). Post-thrombotic syndrome (PTS) was more advanced in group B vs group A, including the prevalence of skin damage and ulceration (61 of 79 vs 26 of 41, P < .001; 29 of 79 vs 6 of 41, P = .019, respectively). Limbs with calf DVT that had focal thrombosis were most often asymptomatic. Calf thrombosis in patients with proximal DVT produced the highest prevalence of PTS. Venous claudication was exclusively found in group B and was present only when iliac veins were involved. Recurrent thrombosis had a trend for a higher prevalence in group B (5 of 41 vs 16 of 79, P = .39). Reflux, obstruction, or a combination of the two were more common in group B (61 of 79) vs group A (15 of 41; P < .0001). Limbs with both reflux and obstruction were more likely to develop skin damage (group A, 5 of 6 vs 1 of 35, P < .0001; group B, 24 of 29 vs 5 of 50, P < .0001).
CONCLUSIONS: Recurrent thrombosis and skin damage is more likely to develop in patients with multiple sites of thrombosis than in those with thrombosis in a single vein segment. Patients with reflux and obstruction presented more skin damage than those with reflux or obstruction alone. Involvement of the calf veins in the presence of proximal vein thrombosis increased the likelihood for PTS.

Entities:  

Mesh:

Year:  2008        PMID: 18515036     DOI: 10.1016/j.jvs.2008.03.016

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  9 in total

1.  Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis.

Authors:  Elham E Amin; Ingrid M Bistervels; Karina Meijer; Lidwine W Tick; Saskia Middeldorp; Guy Mostard; Marlène van de Poel; Erik H Serné; Hans M Otten; Edith M Klappe; Manuela A Joore; Hugo Ten Cate; Marije Ten Wolde; Arina J Ten Cate-Hoek
Journal:  Blood       Date:  2018-09-20       Impact factor: 22.113

2.  Postthrombotic vein wall remodeling: preliminary observations.

Authors:  Kristopher B Deatrick; Megan Elfline; Nichole Baker; Catherine E Luke; Susan Blackburn; Catherine Stabler; Thomas W Wakefield; Peter K Henke
Journal:  J Vasc Surg       Date:  2010-09-24       Impact factor: 4.268

Review 3.  DVT Intervention in the Post-ATTRACT Era.

Authors:  Ronald S Winokur; Akhilesh K Sista
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-08-06

Review 4.  Deep vein thrombosis: current status and nanotechnology advances.

Authors:  Aniket S Wadajkar; Sonia Santimano; Maham Rahimi; Baohong Yuan; Subhash Banerjee; Kytai T Nguyen
Journal:  Biotechnol Adv       Date:  2012-08-23       Impact factor: 14.227

Review 5.  Prevention of the Post-Thrombotic Syndrome.

Authors:  Teresa L Carman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-08

6.  The Anticoagulation of Calf Thrombosis (ACT) project: study protocol for a randomized controlled trial.

Authors:  Daniel Horner; Kerstin Hogg; Richard Body; Michael J Nash; Kevin Mackway-Jones
Journal:  Trials       Date:  2012-04-02       Impact factor: 2.279

7.  Recurrent Deep Vein Thrombosis After the First Venous Thromboembolism Event: A Single-Institution Experience.

Authors:  Mohammad Asim; Hassan Al-Thani; Ayman El-Menyar
Journal:  Med Sci Monit       Date:  2017-05-20

8.  Machine learning-based prediction of the post-thrombotic syndrome: Model development and validation study.

Authors:  Tao Yu; Runnan Shen; Guochang You; Lin Lv; Shimao Kang; Xiaoyan Wang; Jiatang Xu; Dongxi Zhu; Zuqi Xia; Junmeng Zheng; Kai Huang
Journal:  Front Cardiovasc Med       Date:  2022-09-16

9.  Short-Term Anticoagulant Therapy and Thrombus Location Are Independent Risk Factors for Delayed Recanalization of Deep Vein Thrombosis.

Authors:  Chuanlin Zhang; Qining Fu; Yu Zhao; Shaoyu Mu; Liping Liu
Journal:  Med Sci Monit       Date:  2016-01-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.